Veralox Therapeutics Inc. — Form D
Veralox Therapeutics Inc. of FREDERICK, MD, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-22. The offering totals $4.0M, of which $1.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-05-22
- Form: D
- Accession: 0001777474-19-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $1.5M
- Remaining: $2.5M
- Minimum investment: $25K
- Investors: 6
- Date of first sale: 2019-05-10
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-340135
Issuer
- Name: Veralox Therapeutics Inc.
- CIK: 0001777474
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 4539 METROPOLITAN COURT, FREDERICK, MD, 21704
- Phone: (301) 360-3502
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Jonathan W Behr | Director | Boston, MA |
| Matthew W Boxer | Director | Frederick, MD |
| David W Maloney | Director | Frederick, MD |
| Matthew W Boxer | Executive Officer | Frederick, MD |
| David W Maloney | Executive Officer | Frederick, MD |
| Katie Ellias | Director | Miami Beach, FL |
| Jonathan Mow | Director | El Cajon, CA |
| Jonathan Mow | Executive Officer | El Cajon, CA |
| Benjamin Scruggs | Director | Durham, NC |
| Megan Krench | Director | Boston, MA |
| Alex Martin | Director | Frederick, MD |
| Jamie Stiff | Director | Frederick, MD |
| Benjamin W Scruggs | Director | Frederick, MD |
| Jeffrey W Strovel | Director | Frederick, MD |
| Jeffrey W Strovel | Executive Officer | Frederick, MD |
| Jamie W Stiff | Director | Frederick, MD |
| Katie W Ellias | Director | Frederick, MD |
| Christopher W Gagliardi | Director | Frederick, MD |
| Alex W Martin | Director | Frederick, MD |
Other filings by this issuer (2)
More